| Ytd | -31.54% | |
| 1y | -72.87% |
| Open | 1.03 | Prev Close | 1.03 | Low | 1.00 | High | 1.03 | Mkt Cap | 49.18M |
| Vol | 14.69K | Avg Vol | 1.30M | EPS | -0.38 | P/E | N/A | Forward P/E | -7.53 |
| Beta | 0.77 | Short Ratio | 0.19 | Inst. Own | 7.78% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.46 | 200-d Avg | 1.24 | 1yr Est | 21.65 |
GNTA News
MILAN and NAPLES, Italy, July 23, 2026 (GLOBE NEWSWIRE) -- Sòphia High Tech S.r.l. (Sòphia HT), an I
Fiscal Year 2025 Highlights FY2025 sales rose 29.3% to €7.17 million; total value of production incr
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s
Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announce
Genenta Science S.p.A. (NASDAQ:GNTA), evolving into Saentra Forge1, a strategic industrial consolida
Genenta signs Definitive Agreements with Sophia High Tech Genenta enters aerospace as it continues i
Genenta Science S.p.A. (NASDAQ:GNTA), evolving into Saentra Forge1, a strategic industrial consolida
MILAN, March 27, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saent
Focused on selective acquisitions of high-quality companies in strategic industrial sectors Focused
MILAN, March 13, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) transforming to Saen
MILAN, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) in transformation to
Genenta plans a major shift into defense businesses, backing weapons maker ATC, rebranding as Saentr
Building on Biotech Heritage, Expanding into Defense and National Security Through Industrial Integr
MILAN and NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a clinical-sta
Genenta Science S.p.A. Unsponsored ADR (NASDAQ: GNTA - Get Free Report)'s share price rose 0.7% duri
MILAN, Italy and NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a clini
Genenta Science S.p.A. Unsponsored ADR (NASDAQ: GNTA - Get Free Report)'s share price was down 3.4%
Genenta Science S.p.A. initiating with a Buy rating following a 90% stock surge after announcing a s
MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in i
MILAN, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer Company in immuno
MILAN and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in i
Milan, Italy and New York, New York--(Newsfile Corp. - May 8, 2025) - Genenta Science, SpA (NASDAQ: